BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 23504117)

  • 1. Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes.
    Kline GA; Pasieka JL; Harvey A; So B; Dias VC
    Ann Surg Oncol; 2013 Jul; 20(7):2274-8. PubMed ID: 23504117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy.
    Haase M; Riester A; Kröpil P; Hahner S; Degenhart C; Willenberg HS; Reincke M
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4397-402. PubMed ID: 25222758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.
    Dekkers T; Prejbisz A; Kool LJS; Groenewoud HJMM; Velema M; Spiering W; Kołodziejczyk-Kruk S; Arntz M; Kądziela J; Langenhuijsen JF; Kerstens MN; van den Meiracker AH; van den Born BJ; Sweep FCGJ; Hermus ARMM; Januszewicz A; Ligthart-Naber AF; Makai P; van der Wilt GJ; Lenders JWM; Deinum J;
    Lancet Diabetes Endocrinol; 2016 Sep; 4(9):739-746. PubMed ID: 27325147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
    Biglieri EG; Kater CE; Arteaga EE
    J Hypertens Suppl; 1984 Dec; 2(3):S259-61. PubMed ID: 6599673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy?
    Zarnegar R; Bloom AI; Lee J; Kerlan RK; Wilson MW; Laberge JM; Gordon RL; Kebebew E; Clark OH; Duh QY
    J Vasc Interv Radiol; 2008 Jan; 19(1):66-71. PubMed ID: 18192469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism.
    Hennings J; Andreasson S; Botling J; Hägg A; Sundin A; Hellman P
    Langenbecks Arch Surg; 2010 Feb; 395(2):133-7. PubMed ID: 19418066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary aldosteronism: results of adrenalectomy for nonsingle adenoma.
    Quillo AR; Grant CS; Thompson GB; Farley DR; Richards ML; Young WF
    J Am Coll Surg; 2011 Jul; 213(1):106-12; discussion 112-3. PubMed ID: 21489832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hyperaldosteronism diagnosed with adrenal vein sampling. Characteristics and follow-up after adrenalectomy in a Danish study.
    Pedersen M; Karlsen MA; Ankjærgaard KL; Jensen LT
    Scand J Clin Lab Invest; 2016; 76(1):45-50. PubMed ID: 26471096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
    Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
    Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Adrenal Vein Sampling Use and Outcomes in Patients With Primary Aldosteronism.
    Yeung A; Friedmann P; In H; Bloomgarden N; McAuliffe JC; Libutti SK; Laird AM
    J Surg Res; 2020 Dec; 256():673-679. PubMed ID: 32827833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hyperaldosteronism and adrenal incidentaloma: an argument for physiologic testing before adrenalectomy.
    McAlister FA; Lewanczuk RZ
    Can J Surg; 1998 Aug; 41(4):299-305. PubMed ID: 9711163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism.
    Weisbrod AB; Webb RC; Mathur A; Barak S; Abraham SB; Nilubol N; Quezado M; Stratakis CA; Kebebew E
    Ann Surg Oncol; 2013 Mar; 20(3):753-8. PubMed ID: 23090573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.
    Pang TC; Bambach C; Monaghan JC; Sidhu SB; Bune A; Delbridge LW; Sywak MS
    ANZ J Surg; 2007 Sep; 77(9):768-73. PubMed ID: 17685956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary aldosteronism: diagnostic and treatment strategies.
    Mattsson C; Young WF
    Nat Clin Pract Nephrol; 2006 Apr; 2(4):198-208; quiz, 1 p following 230. PubMed ID: 16932426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma.
    Letavernier E; Peyrard S; Amar L; Zinzindohoué F; Fiquet B; Plouin PF
    J Hypertens; 2008 Sep; 26(9):1816-23. PubMed ID: 18698217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Aldosteronism: Does Underlying Pathology Impact Clinical Presentation and Outcomes Following Unilateral Adrenalectomy?
    Shariq OA; Mehta K; Thompson GB; Lyden ML; Farley DR; Bancos I; Dy BM; Young WF; McKenzie TJ
    World J Surg; 2019 Oct; 43(10):2469-2476. PubMed ID: 31214831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
    Amar L; Baguet JP; Bardet S; Chaffanjon P; Chamontin B; Douillard C; Durieux P; Girerd X; Gosse P; Hernigou A; Herpin D; Houillier P; Jeunemaitre X; Joffre F; Kraimps JL; Lefebvre H; Ménégaux F; Mounier-Véhier C; Nussberger J; Pagny JY; Pechère A; Plouin PF; Reznik Y; Steichen O; Tabarin A; Zennaro MC; Zinzindohoue F; Chabre O
    Ann Endocrinol (Paris); 2016 Jul; 77(3):179-86. PubMed ID: 27315757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.